Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
56
MNPR Quote, Financials, Valuation and Earnings
Last price:
$25.33
Seasonality move
:
-3.22%
Day range:
$23.00 - $25.40
52-week range:
$1.55 - $38.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
25.18x
Volume:
58.8K
Avg. volume:
82.1K
1-year change:
1085.67%
Market cap:
$124.6M
Revenue:
--
EPS (TTM):
-$1.99
Earnings Data
Next earnings date for MNPR
Mar 28
2025
Most recent earnings per share
-$0.37
Beat by $0.80
(Nov 8/2024)
Consensus Estimate
-$1.17
(Nov 8/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MNPR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.57 | -- |
| 03/28/2025 | Q4 | -- | -- | -- | -$0.42 | -- |
| 11/08/2024 | Q3 | -- | -- | -$0.37 | -$1.17 | $0.80 |
| 08/09/2024 | Q2 | -- | -- | -$0.50 | -$0.47 | -$0.03 |
| 05/09/2024 | Q1 | -- | -- | -$0.50 | -$0.85 | $0.35 |
| 03/28/2024 | Q4 | -- | -- | -$0.62 | -$0.85 | $0.23 |
| 11/09/2023 | Q3 | -- | -- | -$0.69 | -$0.95 | $0.26 |
| 08/11/2023 | Q2 | -- | -- | -$0.80 | -$0.95 | $0.15 |
| 05/11/2023 | Q1 | -- | -- | -$0.95 | -$1.08 | $0.13 |
| 03/23/2023 | Q4 | -- | -- | -$1.15 | -$1.03 | -$0.13 |
| 11/10/2022 | Q3 | -- | -- | -$0.95 | -$1.08 | $0.13 |
| 08/11/2022 | Q2 | -- | -- | -$1.10 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.95 | -- | -- |
| 03/24/2022 | Q4 | -- | -- | -$1.05 | -- | -- |
| 11/12/2021 | Q3 | -- | -- | -$1.00 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.85 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.80 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$0.95 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$0.75 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.70 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.50 | -- | -- |
| 03/27/2020 | Q4 | -- | -- | -$0.57 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.35 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.43 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.66 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.43 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.31 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.36 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.42 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.34 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$7.14 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.28 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.18 | -- | -- |
Monopar Therapeutics Earnings Questions
-
How Much did Monopar Therapeutics Generate in Revenue Last Quarter?
Monopar Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Monopar Therapeutics Beat Earnings Last Quarter?
Monopar Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$1.17 per share.
-
Is Monopar Therapeutics Profitable?
Monopar Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Monopar Therapeutics EPS Next Year?
Monopar Therapeutics's earnings are forecast to decrease from -$3.05 per share to -$1.77 per share next year representing a decrease of -41.86%.
-
When is Monopar Therapeutics's Earnings Date?
Monopar Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 8
Inari Medical [NARI] is up 22.25% over the past day.
Sell
38
UNF alert for Jan 8
UniFirst [UNF] is up 20.59% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 19.13% over the past day.
